Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 7, 2013 - Issue
Submit an article Journal homepage
71
Views
7
CrossRef citations to date
0
Altmetric
Review

Management of difficult-to-treat patients with ulcerative colitis: focus on adalimumab

Alessandro ArmuzziIBD Unit, Complesso Integrato Columbus, Catholic University, Rome, ItalyCorrespondence[email protected]
,
Daniela PuglieseIBD Unit, Complesso Integrato Columbus, Catholic University, Rome, ItalyCorrespondence[email protected]
,
Olga Maria NardoneIBD Unit, Complesso Integrato Columbus, Catholic University, Rome, ItalyCorrespondence[email protected]
&
Luisa GuidiIBD Unit, Complesso Integrato Columbus, Catholic University, Rome, Italy
Pages 289-296 | Published online: 08 Apr 2013

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Leif Angelison, Sven Almer, Loa Davidsdottir, Per Hammarlund, Stefan Lindgren, Ulf Hindorf, Jan Marsal & Erik Hertervig. (2020) Short and long-term efficacy of adalimumab in ulcerative colitis: a real-life study. Scandinavian Journal of Gastroenterology 55:2, pages 154-162.
Read now
Mark Löwenberg, Nanne KH de Boer & Frank Hoentjen. (2014) Golimumab for the treatment of ulcerative colitis. Clinical and Experimental Gastroenterology 7, pages 53-59.
Read now
Hugh J Freeman. (2013) Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab. Therapeutics and Clinical Risk Management 9, pages 451-456.
Read now

Articles from other publishers (4)

J.L. de-León-Rendón, R.Y. López-Pérez, N.I. Gracida-Mancilla, B. Jiménez-Bobadilla, L. Alarcón-Bernés, S. Mendoza-Ramírez & J.A. Villanueva-Herrero. (2021) The controlling nutritional status score: A promising tool for nutritional screening and predicting severity in ulcerative colitis patients. Revista de Gastroenterología de México (English Edition) 86:2, pages 110-117.
Crossref
J.L. de-León-Rendón, R.Y. López-Pérez, N.I. Gracida-Mancilla, B. Jiménez-Bobadilla, L. Alarcón-Bernés, S. Mendoza-Ramírez & J.A. Villanueva-Herrero. (2021) La escala control nutricional (CONUT): una herramienta prometedora para el cribado nutricional y como predictor de severidad en la colitis ulcerosa crónica idiopática. Revista de Gastroenterología de México 86:2, pages 110-117.
Crossref
Sami Hoque, Amy Puenpatom, Simona Boccaletti, Chloe Green, Christopher M Black, Jenna Roberts, Ivana Rajkovic & Gary Milligan. (2020) Treatment persistence and colectomy-free outcomes in patients with ulcerative colitis receiving golimumab or adalimumab: a UK experience. BMJ Open Gastroenterology 7:1, pages e000476.
Crossref
Bernadette Pöllinger, Wolfgang Schmidt, Anna Seiffert, Heidi Imhoff & Martin Emmert. (2018) Costs of dose escalation among ulcerative colitis patients treated with adalimumab in Germany. The European Journal of Health Economics 20:2, pages 195-203.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.